Table 1 Descriptive characteristics
From: Post-covid medical complaints following infection with SARS-CoV-2 Omicron vs Delta variants
SARS-CoV-2 Omicron variant | SARS-CoV-2 Delta variant | Testing negative for SARS-CoV-2 | |
|---|---|---|---|
13,365 | 23,767 | N = 105,297 | |
Age, median (interquartile range) | 36 (26–48) | 40 (32–49) | 42 (30–53) |
Women, n (%) | 6638 (49.7) | 11,711 (49.3) | 52,905 (50.2) |
Primary schoola, n (%) | 2886 (21.7) | 5183 (21.9) | 21,341 (20.3) |
Upper secondary schoola, n (%) | 4179 (31.4) | 7821 (33.0) | 35,848 (34.2) |
College/universitya, n (%) | 5461 (41.0) | 8948 (37.8) | 41,180 (39.3) |
Born in Norway, n (%) | 9520 (71.2) | 16,138 (67.9) | 79,686 (75.7) |
≥2 comorbiditiesb, n (%) | 1169 (8.7) | 2604 (11.0) | 12,858 (12.2) |
One vaccine dosec, n (%) | 12,463 (93.2) | 18,822 (79.2) | 97,964 (93.0) |
Two vaccine dosesc, n (%) | 12,119 (90.7) | 18,011 (75.8) | 94,183 (89.4) |
Three vaccine dosesc, n (%) | 1421 (10.6) | 1430 (6.0) | 17,362 (16.5) |
Nr. of negative testsd, median [IQR] | 2 [1–4] | 2 [1–4] | 1 [0–3] |
Nr. of all-cause previous visits to primary caree, median [IQR] | 2 [1–3] | 2 [1–4] | 2 [1–3] |
